http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11536717-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_421cadb30fc0074fe61126eb980d19d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c190c99174dfe46deef72ae3ad792590 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-1734 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-31 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-17 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31 |
filingDate | 2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bc46422cdd2f7488c6fd7e2fe38bc84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d2d22aeef71e9c5cbab44463f9c446a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45e4591f67886d8e3ba385d94bf47bd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe50d274d4bea765caca59eab46cd417 |
publicationDate | 2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-11536717-B2 |
titleOfInvention | Method of agglutination immunoassay |
abstract | The present invention provides a particle enhanced agglutination immunoassay including the steps of: mixing a sample solution containing an analyte with a solution containing insoluble carrier particles carrying a binding partner or binding partners for the analyte to prepare a mixed solution; determining a variation (i) in intensity of light scattered from the mixed solution based on a difference in intensity of scattered light between first and second time points; determining a variation (ii) in absorbance of the mixed solution based on a difference in absorbance between third and fourth time points; and correlating the determined variation (i) in intensity of scattered light and the determined variation (ii) in absorbance with an amount of the analyte present in the sample using a calibration curve plotted based on the variation in intensity of scattered light and a calibration curve plotted based on the variation in absorbance. The present invention employs measurements of the intensity of scattered light and the absorbance in combination for a single assay, and thus provides a particle enhanced agglutination immunoassay which achieves higher sensitivity and a wider dynamic range than conventional assays. |
priorityDate | 2013-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.